5-fluorouracil induces apoptosis through the suppression of NF-κB activity in human salivary gland cancer cells

Biochemical and Biophysical Research Communications

Volumn 273, Issue 3, 2000, Pages 1168-1174

  Aota, Keiko ^a   Azuma, Masayuki ^a   Yamashita, Tsuyoshi ^a   Tamatani, Tetsuya ^a   Motegi, Katsumi ^a   Ishimaru, Naozumi ^a   Hayashi, Yoshio ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

5 FU; Apoptosis; Caspase 3; Caspase 8; CIAP 1; Fas; I B ; NF B; Salivary gland cancer cells; TRAF 2

Indexed keywords

CASPASE 3; CASPASE 8; FAS ANTIGEN; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME INDUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SALIVARY GLAND CANCER;

EID: 0034647959     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3072     Document Type: Article

References (30)

1. Beg A. A., Sha W. C., Bronson R. T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 376:1995;167-170.
2. Cai Z., Korner M., Tarantino N., Chouaib S. IκB-α overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factor-α-induced apoptosis. J. Biol. Chem. 272:1997;96-101.
3. Bargou R. C., Emmerich F., Krappmann D., Bommert K., Mapara M. Y., Arnold W., Royer H. D., Grinstein E., Greiner A., Scheidereit C., Dorken B. Constitutive nuclear factor-kappa B-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest. 100:1997;2961-2969.
4. Sovak M. A., Bellas R. E., Kim D. W., Zanieski G. J., Rogers A. E., Traish A. M., Sonenshein G. E. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:1997;2952-2960.
5. Azuma M., Motegi K., Aota K., Yamashita T., Yoshida H., Sato M. TGF-β1 inhibits NF-κB activity through induction of IκB-α expression in human salivary gland cells: A possible mechanism of growth suppression by TGF-β1. Exp. Cell Res. 250:1999;213-222.
6. Beg A. A., Baltimore D. An essential role for NF-κB in preventing TNF-α induced cell death. Science. 274:1996;782-784.
7. Wang C.-Y., Mayo M. W., Baldwin A. S. Jr. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
8. Van Antwerp D. J., Marin S. J., Kafri T., Green D. R., Verma I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:1996;787-789.
9. Speiser D. E., Lee S. Y., Wong B., Arron J., Santana A., Kong Y.-Y., Ohashi P. S., Choi Y. A regulatory role for TRAF-1 in antigen-induced apoptosis of T cells. J. Exp. Med. 185:1997;1777-1783.
10. Wang C. Y., Mayo M. W., Korneluk R. G., Goeddel D. V., Baldwin A. S. Jr. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.
11. Azuma M., Tamatani T., Fukui K., Yoshida H., Kamogashira T., Ogino K., Suzuki T., Sato M. Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary gland adenocarcinoma cells. Int. J. Cancer. 54:1993;669-676.
12. Petri E., Milano G., Levi F., Thyss A., Bailleul F., Schneider M. Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients. Cancer Res. 48:1988;1676-1679.
13. Azuma M., Aota K., Tamatani T., Motegi K., Yamashita T., Harada K., Hayashi Y., Sato M. Suppression of tumor necrosis factor-α-induced matrix metalloproteinase-9 production by introduction of a super-repressor form of IκB-α cDNA into immortalized human salivary gland acinar cells: Prevention of destruction of acinar structure in Sjögren's syndrome salivary glands. Arthritis Rheum. 2000.
14. Claudi E., Segada F., Wrobel K., Ramos S., Bravo R., Lazo P. S. Molecular mechanism of TNFα cytotoxicity: Activation of NF-κB and nuclear translocation. Exp. Cell Res. 224:1996;63-71.
15. Imbert V., Rupec R. A., Livolsi A., Pahl H. L., Traenckner E. B.-M., Mueller-Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P. A., Peyron J.-F. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α Cell. 86:1996;787-798.
16. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
17. Narayanan R., Higgins K. A., Perez J. R., Coleman T. A., Rosen C. A. Evidence for differential functions of the p50 and p65 subunits of NF-κB with a cell adhesion model. Mol. Cell. Biol. 13:1993;3802-3810.
18. Yamaguchi F., Saya H., Bruner J. M., Morrison R. S. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl. Acad. Sci. USA. 91:1994;484-488.
19. Ishimaru N., Saegusa K., Yanagi K., Haneji N., Saito I., Hayashi Y. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through Fas-mediated apoptosis. Am. J. Pathol. 155:1999;173-181.
20. Chiao P. J., Miyamoto S., Verma I. M. Autoregulation of IκB-α activity. Proc. Natl. Acad. Sci. USA. 91:1994;28-32.
21. Lazebnik Y. A., Kaufmann S. H., Desnoyers S., Poirier G. G., Earnshaw W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
22. Ueda M., Kumagai K., Ueki K., Inoki C., Orino I., Ueki M. Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-Fluorouracil. Int. J. Cancer. 71:1997;668-674.
23. Tillman D. M., Petak I., Houghton J. A. A Fas-dependent component in 5-Fluorouracil/Leucovorin-induced cytotoxicity in colon carcinoma cells. Clin. Cancer Res. 5:1999;425-430.
24. Spears C. P., Gustavsson B. G., Mitchell M. S., Spicer D., Berne M., Bernstein L., Danenberg P. V. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res. 44:1984;4144-4150.
25. Cory J. G., Breland J. C., Carter G. L. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells. Cancer Res. 39:1979;4905-4913.
26. Das K. C., White C. W. Activation of NF-κB by antineoplastic agents. J. Biol. Chem. 272:1997;14914-14920.
27. Spencer W., Kwon H., Crépieux P., Leclerc N., Lin R., Hiscott J. Taxol selectively blocks microtubule dependent NF-κB activation by phorbol ester via inhibition of IκB-α phosphorylation and degradation. Oncogene. 18:1999;495-505.
28. Yamamoto Y., Yin M.-J., Lin K.-M., Gaynor R. B. Sulindac inhibits activation of the NF-κB pathway. J. Biol. Chem. 274:1999;27307-27314.
29. Martinon F., Holler N., Richard C., Tschopp J. Activation of a pro-apoptotic amplification loop through inhibition of NF-κB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett. 468:2000;134-136.
30. Thronberry N., Lazebnik Y. Caspases: Enemies within. Science. 282:1998;1312-1316.